Viewing Study NCT02182258


Ignite Creation Date: 2025-12-25 @ 12:01 AM
Ignite Modification Date: 2026-01-11 @ 3:26 AM
Study NCT ID: NCT02182258
Status: COMPLETED
Last Update Posted: 2014-07-18
First Post: 2014-07-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Tolerability Study of BIBF 1120 as Intravenous Infusion and Absolute Bioavailability of BIBF 1120 as Soft Gelatine Capsule in Healthy Subjects
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module